|
Cmc-thuggacin A |
12 |
0.47 |
0.42 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C(C)/C=C(\C)CC(C)C(O)C(O)C1C/C=C\C=C/C(O)CC(O)C(CO)c2nc(cs2)/C=C(/C)C(=O)O1 |
view |
Cmc-thuggacin A |
|
|
thailandamide A |
0 |
0.53 |
0.48 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C/C=C(C)/C=C/[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide A |
|
|
thailandamide B |
1 |
0.53 |
0.48 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C\C=C(C)\C=C\[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide B |
|
|
Elansolid A1 |
2 |
0.52 |
0.54 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
COC(c1ccc(O)cc1)C1C(/C=C\C=C\C=C/C(O)C(C)C(O)C/C=C(C)/C=C/C(=O)O)C(C)=CC2C1C(C)(C)C[C@]2(C)O |
view |
Elansolid A1 |
|
|
phenalamide |
3 |
0.5 |
0.54 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C(\C)C(=O)NC(C)CO)=C\C(C)C(O)/C(C)=C/C(C)CCc1ccccc1 |
view |
phenalamide |
|
|
fumagillin |
4 |
0.49 |
0.42 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2 |
view |
fumagillin |
|
|
isorenieratene |
5 |
0.49 |
0.46 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\c1c(C)ccc(C)c1C |
view |
isorenieratene |
|
|
alpha-lipomycin |
6 |
0.49 |
0.42 |
0.54 |
0.5 |
Glyco:1/3 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
naphthomycin |
7 |
0.48 |
0.45 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C1=C/C[C@H](O)/C=C\[C@H](C)[C@H](O)[C@@H](C)/C=C(/C)C(=O)c2c(O)c(C)cc3c2C(=O)C(Cl)=C(NC(=O)/C(C)=C\C=C/C=C\[C@H](C)[C@@H](O)CC1=O)C3=O |
view |
naphthomycin |
|
|
thailandamide lactone |
8 |
0.48 |
0.44 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H]1[C@@H](C)C(=O)O[C@@]1(C)/C=C/C=C/C(C)=C/C=C/C(O)=C/C(=O)/C=C/C=C(C)/C=C/[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1 |
view |
thailandamide lactone |
|
|
AK-toxin |
9 |
0.48 |
0.46 |
0.61 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)NC(C(=O)OC(/C=C/C=C\C=C\C(=O)O)C1(C)CO1)C(C)c1ccccc1 |
view |
AK-toxin |
|
|
heronamide E |
10 |
0.47 |
0.42 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@H]3C=C[C@@H](O)[C@@H](O)[C@@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide E |
|
|
enacyloxin |
11 |
0.47 |
0.42 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C/[C@@H](OC(N)=O)[C@@H](Cl)[C@H](O)CC(=O)C(O)C(O)[C@H](C)/C(Cl)=C/C=C/C=C(C)/C=C/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)O)CC[C@@H]1O |
view |
enacyloxin |
|
|
Cmc-thuggacin B |
13 |
0.47 |
0.42 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C(C)/C=C(\C)CC(C)C1OC(=O)/C(C)=C\c2csc(n2)C(CO)C(O)CC(O)/C=C\C=C/CC(O)C1O |
view |
Cmc-thuggacin B |
|
|
isobongkrekic acid |
14 |
0.47 |
0.44 |
0.61 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H](C/C=C\C=C\CC/C=C/C[C@H](C)/C=C/C(=C/C(=O)O)CC(=O)O)/C(C)=C\C=C(C)C |
view |
isobongkrekic acid |
|
|
azaspirene |
15 |
0.46 |
0.42 |
0.61 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C/C=C/C1=C(C)C(=O)C2(O1)C(=O)N[C@@](O)(Cc1ccccc1)[C@@H]2O |
view |
azaspirene |
|
|
heronamide C |
16 |
0.46 |
0.42 |
0.6 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC/C=C\C=C/C[C@H]1C/C=C\C=C(C)/C=C\C=C/[C@H](O)[C@H](O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
heronamide C |
|
|
hitachimycin |
17 |
0.46 |
0.45 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H]1C[C@@H]2/C=C(C)\C=C/C=C\C(=O)N[C@@H](c3ccccc3)C/C=C\CC[C@H](O)CC(=O)C2=C1O |
view |
hitachimycin |
|
|
heronamide D |
18 |
0.46 |
0.43 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/CC1C[C@H](O)C2C3/C(C)=C\C4C=C[C@@H](O)[C@@H](O)C4/C(C)=C\C=C/C3C(=O)N12 |
view |
heronamide D |
|
|
bongkrekic acid |
19 |
0.46 |
0.43 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
COC(C/C=C\C=C\CC/C=C/CC(C)/C=C/C(=C\C(=O)O)CC(=O)O)/C(C)=C\C=C(/C)C(=O)O |
view |
bongkrekic acid |
|
|
myxalamid |
20 |
0.45 |
0.42 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(/C=C/C=C\C=C\C=C(/C)C(=O)N[C@@H](C)CO)=C\[C@@H](C)[C@@H](O)/C(C)=C/C(C)C |
view |
myxalamid |
|
|
Dawenol |
21 |
0.45 |
0.42 |
0.58 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C(C)=C\C(C)C(O)C(C)C(C)OC(C)=O |
view |
Dawenol |
|
|
crocacin |
22 |
0.45 |
0.42 |
0.58 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
COC(=O)CNC(=O)/C=C\C/C=C\NC(=O)/C=C(C)/C=C/[C@H](C)[C@H](OC)[C@H](C)[C@H](/C=C/c1ccccc1)OC |
view |
crocacin |
|
|
BE-14106 |
23 |
0.45 |
0.43 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC/C=C/CC1C/C=C\C=C(C)/C=C\C=C/C(O)C(O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
BE-14106 |
|
|
Xenortide C |
24 |
0.45 |
0.49 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1ccccc1)C(C)C |
view |
Xenortide C |
|
|
heronamide A |
25 |
0.44 |
0.42 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@H](O)C2[C@@H]3/C(C)=C\[C@@H]4C=C[C@H](O)[C@H](O)[C@H]4/C(C)=C\C=C/[C@H]3C(=O)N21 |
view |
heronamide A |
|
|
Sevadicin |
26 |
0.44 |
0.42 |
0.56 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(NC(=O)C(N)Cc1ccccc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O |
view |
Sevadicin |
|
|
Xenortide A |
27 |
0.44 |
0.5 |
0.51 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1ccccc1 |
view |
Xenortide A |
|
|
communesin D communesin E |
28 |
0.43 |
0.42 |
0.54 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/C(=O)N1CC[C@@]23c4ccccc4N[C@@H]4N(C=O)c5cccc6c5[C@@]42CCN([C@@H]6[C@H]2OC2(C)C)[C@@H]13 |
view |
communesin D communesin E |
|
|
nannocystin a |
29 |
0.43 |
0.44 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H](C)[C@H]1C(=O)N[C@H](Cc2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@@H](C(C)(C)O)C(=O)O[C@H](c2ccccc2)[C@H](C)/C=C\C=C(\C)[C@H](OC)C[C@@H]2O[C@@]2(C)C(=O)N1C |
view |
nannocystin a |
|
|
Xenortide B |
30 |
0.42 |
0.42 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1c[nH]c2ccccc12 |
view |
Xenortide B |
|
|
Microsclerodermin M |
31 |
0.42 |
0.43 |
0.51 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN1CC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)NCC(=O)NC[C@H](O)CC(=O)N[C@H]([C@H](O)[C@@H](O)C/C=C/C=C/C=C/c2ccccc2)[C@H](O)C(=O)N[C@@H]2CC(=O)N[C@@]2(O)CC1=O |
view |
Microsclerodermin M |
|
|
cytochalasin K |
32 |
0.42 |
0.43 |
0.51 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC1=C(C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)O/C=C\[C@@](C)(O)C(=O)[C@@H](C)C/C=C\[C@H]3[C@@H]1O |
view |
cytochalasin K |
|
|
bacillaene |
33 |
0.39 |
0.43 |
0.45 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C(=C/C=C/C=C/C(C)C(=O)O)NC(=O)CC(O)/C(C)=C\C=C/C=C(C)/C=C/C=C\CCCNC(=O)C(O)CC(C)C |
view |
bacillaene |
|
|
andrimid |
34 |
0.37 |
0.42 |
0.42 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/C=C/C(=O)N[C@@H](CC(=O)N[C@H](C(=O)[C@@H]1C(=O)NC(=O)[C@H]1C)C(C)C)c1ccccc1 |
view |
andrimid |
|
|
pacidamycin 5 |
35 |
0.37 |
0.45 |
0.4 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N/C=C1/C[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1)[C@H](C)N(C)C(=O)[C@@H](N)Cc1cccc(O)c1 |
view |
pacidamycin 5 |
|
|
Ambactin |
36 |
0.37 |
0.47 |
0.39 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2ccccc2)NC1=O |
view |
Ambactin |
|
|
napsamycin B |
37 |
0.36 |
0.42 |
0.41 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CSCC[C@H](NC(=O)NC(Cc1cccc(O)c1)C(=O)O)C(=O)N(/C=C1\CC(O)C(n2ccc(=O)[nH]c2=O)O1)C(=O)C(N)C(C)N(C)C(=O)C1Cc2cc(O)ccc2C(C)N1 |
view |
napsamycin B |
|
|
napsamycin A |
38 |
0.36 |
0.41 |
0.41 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CSCC[C@H](NC(=O)NC(Cc1cccc(O)c1)C(=O)O)C(=O)N(/C=C1\CC(O)C(n2ccc(=O)[nH]c2=O)O1)C(=O)C(N)C(C)N(C)C(=O)C1Cc2cc(O)ccc2CN1 |
view |
napsamycin A |
|
|
nostamide A |
39 |
0.36 |
0.45 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@@H](C)[C@@H]1NC(=O)[C@H](NC(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCCNC(=O)[C@H](CCc2ccc(O)cc2)NC(=O)CN(C)C(=O)[C@H](CCc2ccccc2)NC1=O |
view |
nostamide A |
|
|
mureidomycin A |
40 |
0.36 |
0.44 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CSCC[C@H](NC(=O)NC(Cc1cccc(O)c1)C(=O)O)C(=O)N(/C=C1\CC(O)C(n2ccc(=O)[nH]c2=O)O1)C(=O)C(N)C(C)N(C)C(=O)[C@@H](N)Cc1cccc(O)c1 |
view |
mureidomycin A |
|
|
pacidamycin 2 |
41 |
0.36 |
0.44 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@H](N)C(=O)N[C@@H](Cc1cccc(O)c1)C(=O)N(C)[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N/C=C1/C[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1 |
view |
pacidamycin 2 |
|
|
mureidomycin B |
42 |
0.36 |
0.44 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CSCCC(NC(=O)NC(Cc1cccc(O)c1)C(=O)O)C(=O)NC(C(=O)N/C=C1\CC(O)C(N2CCC(=O)NC2=O)O1)C(C)N(C)C(=O)C(N)Cc1cccc(O)c1 |
view |
mureidomycin B |
|
|
pacidamycin 7 |
43 |
0.35 |
0.43 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N/C=C1/C[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1)[C@H](C)N(C)C(=O)[C@H](Cc1cccc(O)c1)NC(=O)CN |
view |
pacidamycin 7 |
|
|
beauvericin |
44 |
0.35 |
0.43 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)[C@H]1OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H](C(C)C)OC(=O)[C@H](Cc2ccccc2)N(C)C1=O |
view |
beauvericin |
|
|
nostocyclopeptide |
45 |
0.35 |
0.42 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H](C)[C@@H]1NC(=O)[C@@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)/N=C\[C@H](Cc2ccccc2)NC(=O)[C@@H]2C[C@H](C)CN2C(=O)[C@H](CO)NC1=O |
view |
nostocyclopeptide |
|
|
anabaenopeptin NZ 857 |
46 |
0.35 |
0.42 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@@H](C)[C@@H]1NC(=O)C(NC(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCCNC(=O)[C@H](CCc2ccc(O)cc2)NC(=O)CN(C)C(=O)C(CCc2ccc(O)cc2)NC1=O |
view |
anabaenopeptin NZ 857 |
|
|
anabaenopeptin |
47 |
0.35 |
0.42 |
0.38 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)[C@@H]1NC(=O)[C@H](NC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)CCCCNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](CCc2ccc(O)cc2)N(C)C1=O |
view |
anabaenopeptin |
|
|
Desmethylsalinamide E |
48 |
0.34 |
0.43 |
0.35 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](C)[C@H](O)C(C)C)[C@@H](C)OC(=O)[C@H](CO)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](c2ccc(O)cc2)NC1=O |
view |
Desmethylsalinamide E |
|
|
virginiamycin |
49 |
0.33 |
0.42 |
0.34 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccccc2)N(C)C(=O)C2CCCN2C1=O |
view |
virginiamycin |
|